Hester Biosciences Q3 Results
- BSE: 524669
- NSE: HESTERBIO
- ISIN: INE782E01017
- Sector: Biotechnology & Drugs
BSE
2,049.90
-19.60 (-0.95%)
-19.60 (-0.95%)Volume513.00
Updated: Tue 16 Jun, 2026 | 09:58:32
NSE
2,058-8.60 (-0.42%)
-8.60 (-0.42%)Volume4.83 K
Updated: Tue 16 Jun, 2026 | 14:16:15
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Hester Biosciences Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 64.05 | 68.73 | 0.70% | 60.58 | 2.57% |
| Depreciation/ Amortization | 4.43 | 4.20 | 1.77% | 3.75 | 3.26% |
| Operating Income | 13.36 | 14.96 | 81.45% | 6.41 | 1635.32% |
| Net Income | 8.77 | 8.20 | -39.34% | 3.98 | -24.84% |
| Other Operating Expenses Total | 23.38 | 24.12 | -4.32% | 20.61 | 5.34% |
| Net Income Before Taxes | 13.52 | 11.87 | -20.62% | 6.41 | 1.18% |
| Total Revenue | 77.41 | 83.69 | 9.08% | 66.98 | 22.46% |
| Selling/ General/ Admin Expenses Total | 15.52 | 15.90 | 0.11% | 15.58 | -5.04% |
| Diluted Normalized EPS | 10.94 | 9.86 | -35.07% | 4.73 | -18.42% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.